Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04585581 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Preconception Lifestyle Interventions to Improve Future Metabolic Health (Before the Beginning)

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv8
  2. Minor Primary completion date changed from estimate of Aug 2024 to Feb 5, 2024
    • Study completion date: Dec 2024 to Dec 2026
    v7
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 260 to confirmed 167
    • Site details revised
    v6
  4. Minor Study completion date: Aug 2024 to Dec 2024v5
  5. Minor Secondary endpoints: 40 to 44v4
Show 2 earlier versionsHide 2 earlier versions
  1. Minor Re-verified, no change to tracked fieldsv3
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Primary and study completion dates: Jul 2024 to Aug 2024
    • Start date changed from estimate of Oct 2020 to Nov 6, 2020
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to investigate whether the combination of high intensity exercise and time restricted eating before and during pregnancy can reduce the risk of hyperglycaemia during pregnancy.
Trial Details
NCT Number NCT04585581
Lead Sponsor Norwegian University of Science and Technology
Collaborators: St. Olavs Hospital
Conditions
(from sponsor)
Gestational Diabetes
Related terms Diabetes, Gestational
Enrollment 167 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov